Amid the nationwide outrage over children's deaths caused by adulterated cough syrups in Madhya Pradesh and Rajasthan, the World Health Organization (WHO) has expressed concern over the "regulatory gap" in screening for diethylene glycol and ethylene glycol for domestically marketed medicines in India. It has also flagged the potential risk of such contaminated products being exported to other countries, particularly via unregulated channels.